Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Teva Pharmaceutical Industries Ltd

+ Add to Watchlist

TEVA:IT

22,350.00 ILs 220.00 0.99%

As of 10:24:52 ET on 02/26/2015.

Snapshot for Teva Pharmaceutical Industries Ltd (TEVA)

Open: 22,350.00 Day's Range: 22,270.00 - 22,430.00 Volume: 768,287
Previous Close: 22,130.00 52wk Range: 16,750.00 - 23,770.00 1-Yr Rtn: +35.34%

Stock Chart for TEVA

No chart data available.
  • TEVA:IT 22,350.00
  • 1D
  • 1M
  • 1Y
22,130.00
Interactive TEVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TEVA

Current P/E Ratio (ttm) 15.6643
Estimated P/E(12/2015) 10.9122
Relative P/E vs. TA-100 1,789.6549
Earnings Per Share (USD) (ttm) 3.5800
Est. EPS (USD) (12/2015) 5.1450
Est. PEG Ratio 3.1565
Market Cap (M ILS) 190,422.00
Shares Outstanding (M) 852.00
30 Day Average Volume 415,341
Price/Book (mrq) 2.0569
Price/Sale (ttm) 2.3593
Dividend Indicated Gross Yield 2.38%
Cash Dividend (ILs) 133.0000
Dividend Ex-Date 02/19/2015
5 Year Dividend Growth 14.69%
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TEVA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TEVA

Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.

Erez VigodmanPresident/CEOEyal DeshehGroup Exec VP/CFO
Richard S EgosiGroup Exec VP/Chief Legal OfficerMark SabagGroup Exec VP:Human Resources
More Company Profile & Key Executives for TEVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil